The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Product liability: The publishers cannot guarantee the accuracy of any information about the application of operative techniques and medications contained in this book. In every individual case the user must check such information by consulting the relevant literature. Production: PRO EDIT GmbH, D-69126 Heidelberg Cover design: Design & Production, D-69121 Heidelberg Typesetting: K+V Fotosatz GmbH, D-64743 Beerfelden SPIN 10716205 27/3136-5 4 3 2 1 0
PrefaceThe idea that the brain is an "immune-privileged site" has perhaps served to slow our realization that the intact brain can generate its own inflammatory reactions. These responses can be to peripheral infection, or they can arise from local, internal causes, for instance as a response to stress or to the severe changes in neuronal activity in seizure or the loss of oxygen in stroke. We are also becoming increasingly aware of the contribution of local inflammatory reactions to certain neurodegenerative diseases such as Alzheimer's disease (AD). In fact, evidence is accumulating that inflammatory processes contribute to the progression of AD, suggesting the possibility of using currently available or novel anti-inflammatory agents to interfere with this terrible disease. Correlations are also being made between inflammatory signs and mental illness, which is a new frontier of research.This book presents the current state of knowledge in a variety of areas relevant to neuro-immune interactions, with particular attention to AD. These chapters summarize presentations made at the October 5, 1998 meeting of the Fondation IPSEN, in Paris. Inflammation has been linked to AD both from epidemiological work and from neuropathological studies of the brain. Correlations have been made between taking anti-inflammatory drugs and postponing the onset of AD, and a variety of inflammatory markers have been localized to the senile plaques, the latter being diagnostic for AD pathology. These and related topics are discussed by Joseph Rogers and Sue Griffin in this volume. The use of transgenic mice to study AD is described by Lennert Mucke and Paul Patterson, who present new findings on the interplay of cytokines and apolipoprotein E (ApoE), and the use of anti-inflammatory drugs in this animal model. Mucke also presented novel work on the use of inducible promoters in controlling amyloid precursor protein (APP) and ApoE in new mouse models. The involvement of microglia, the phagocytic inflammatory cells of the brain, in this inflammatory reaction is discussed by Barbara Cordell, who is investigating the role of cytokines in the interaction between neurons and glia in culture. Giulio Levi also reports on the control of microglial activation and the role of cAMP. The role of the inflammatory regulator NF-KB in the micr...